|
1
|
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
|
Cancer Res
|
2000
|
3.02
|
|
2
|
Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity.
|
J Biol Chem
|
1993
|
2.62
|
|
3
|
Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
|
Cancer Res
|
1996
|
2.10
|
|
4
|
Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.
|
FASEB J
|
2001
|
1.83
|
|
5
|
Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
|
Cancer Res
|
2000
|
1.79
|
|
6
|
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
|
J Biol Chem
|
1997
|
1.41
|
|
7
|
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.
|
Breast Cancer Res Treat
|
1995
|
1.26
|
|
8
|
Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors.
|
Angiogenesis
|
2001
|
1.25
|
|
9
|
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.
|
J Med Chem
|
2000
|
1.21
|
|
10
|
Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
|
Cancer Res
|
1999
|
1.17
|
|
11
|
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
|
Cancer Res
|
1997
|
1.10
|
|
12
|
Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood.
|
Angiogenesis
|
2001
|
1.08
|
|
13
|
Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
|
Biochem Biophys Res Commun
|
1996
|
0.95
|
|
14
|
Active interaction of human A375 melanoma cells with the lymphatics in vivo.
|
Histochem Cell Biol
|
2000
|
0.95
|
|
15
|
VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane.
|
Dev Biol
|
1996
|
0.92
|
|
16
|
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
|
Proc Natl Acad Sci U S A
|
1998
|
0.92
|
|
17
|
The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.
|
Cancer Metastasis Rev
|
1998
|
0.87
|
|
18
|
Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro.
|
Biochim Biophys Acta
|
2000
|
0.85
|
|
19
|
The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
|
J Biol Chem
|
1998
|
0.83
|
|
20
|
Donor stromal cells from human blood engraft in NOD/SCID mice.
|
Blood
|
2000
|
0.80
|
|
21
|
A new set of regulatory molecules in plants: A plant phospholipid similar to platelet-activating factor stimulates protein kinase and proton-translocating ATPase in membrane vesicles.
|
Planta
|
1988
|
0.78
|
|
22
|
Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates.
|
Clin Chem
|
1996
|
0.77
|
|
23
|
Novel antibodies directed against the extracellular domain of the human VEGF-receptor type II.
|
Hybridoma
|
1997
|
0.77
|
|
24
|
Molecular aspects of the neuronal noradrenaline transporter.
|
J Neural Transm Suppl
|
1991
|
0.75
|
|
25
|
Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter.
|
J Neural Transm Suppl
|
1990
|
0.75
|